Endothelial Arginase II: A Novel Target for the Treatment of Atherosclerosis

Circulation Research - United States
doi 10.1161/circresaha.107.169573
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Arginase - A Novel Target for Cardioprotection by Vagal Nerve Stimulation

Acta Physiologica
Physiology
2017English

Generation of a Mouse Model for Arginase II Deficiency by Targeted Disruption of the Arginase II Gene

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2001English

FXR an Emerging Therapeutic Target for the Treatment of Atherosclerosis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2009English

Vessel Pruning or Healing: Endothelial Metabolism as a Novel Target?

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2017English

SY13-1Vasohibin-2 Is a Novel Molecular Target for the Treatment of Gastrointestinal Cancers

Annals of Oncology
MedicineOncologyHematology
2018English

Erratum To: Iron and Atherosclerosis: Nailing Down a Novel Target With Magnetic Resonance

Journal of Cardiovascular Translational Research
GeneticsPharmaceutical ScienceCardiovascular MedicineMolecular MedicineCardiology
2014English

Endocannabinoid System as Novel Therapeutic Target for Autism Treatment

Autism-Open Access
2014English

Expression of Arginase II in Prostate Cancer

International Journal of Oncology
Cancer ResearchOncology
2008English

Competitive Metabolism of L -Arginine: Arginase as a Therapeutic Target in Asthma

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy